Obsessive-Compulsive Disorder (OCD) Support Protocol
Primary Stack
Core supplements with strongest evidenceModulates glutamate; studied as adjunct to standard OCD treatment
Supporting Studies (1)
May affect serotonin signaling; studied for anxiety and OCD
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsSupports brain function; anti-inflammatory
Supporting Studies (1)
Deficiency linked to various psychiatric conditions
Supporting Studies (1)
Supports nervous system function; may help with anxiety
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Obsessive-Compulsive Disorder (OCD) is a mental health condition characterized by unwanted, intrusive thoughts (obsessions) and repetitive behaviors (compulsions) performed to reduce anxiety.
OBSESSIONS (intrusive thoughts):
COMPULSIONS (repetitive behaviors):
KEY FEATURES:
FIRST-LINE TREATMENTS:
CRITICAL: OCD requires professional treatment. Supplements are adjunctive only.
* NAC has the most evidence as an adjunct.
* ERP therapy is the most effective treatment.
* SSRIs often require higher doses for OCD than depression.
Expected timeline: ERP shows improvement over 12-20 sessions. SSRIs may take 8-12 weeks. NAC studied over 12+ weeks as adjunct.
Clinical Perspective
OCD: Chronic disorder characterized by obsessions and/or compulsions. Onset usually adolescence/young adulthood. Lifetime prevalence ~2-3%. Often comorbid with depression, anxiety, tic disorders.
Treatment: ERP (Exposure and Response Prevention) is gold-standard psychotherapy. SSRIs first-line pharmacotherapy - typically higher doses than depression (e.g., fluoxetine up to 80mg). Clomipramine effective but more side effects. Treatment-resistant: augment with antipsychotic, try different SSRI, consider TMS, DBS. NAC: most evidence among supplements as adjunct (glutamate modulation). Inositol: limited evidence. Supplements adjunctive only - do not replace evidence-based treatment.
* NAC (B-grade): Glutamate modulation. RCT: (PMID: 24698062). 2400-3000mg daily.
* Inositol (C-grade): Serotonin signaling. Study: (PMID: 9169302). 12-18g daily.
* Omega-3 (C-grade): Brain health. Systematic review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Vitamin D (C-grade): Mental health. Review: (PMID: 28750270). 2000-4000 IU daily.
* Magnesium (C-grade): Anxiety. Systematic review: (PMID: 28445426). 300-400mg daily.
Protocol notes: Diagnosis: Y-BOCS for severity; rule out tic disorders, body dysmorphic disorder. ERP: systematic exposure to triggers while preventing compulsive response; highly effective but requires specialized therapist. SSRIs: 8-12 weeks adequate trial; higher doses often needed. Clomipramine: effective but anticholinergic side effects. Augmentation: low-dose antipsychotic if partial response. NAC: add to SSRI; well-tolerated. Treatment-resistant: consider specialized OCD programs, TMS, DBS in severe cases. PANDAS/PANS: sudden onset OCD in children - consider infection-triggered autoimmune mechanism.